The Grünenthal Group
The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany.
Building on its unique position in pain treatment, its objective is to become the most patient-centric company and thus to be a leader in therapy innovation. Grünenthal is one of the last remaining five research-oriented pharmaceutical companies with headquarters in Germany which sustainably invests in research and development. These investments amounted to about 20 percent of revenues in 2014.
Clinical trial disclosure
As of today the Grünenthal Internet Clinical Trial Portal provides public access to information about clinical trials sponsored by Grünenthal.
As a research-based pharmaceutical company, Grünenthal recognizes the importance of publicly sharing information about clinical trials. The launch of this portal illustrates Grünenthal’s commitment to enhance research and patient care by providing public access to information (including results) about its interventional clinical trials in patients.